OBJECTIVES: To test the hypothesis that limits on repeating laboratory studies within computerized provider order entry decrease laboratory utilization. DESIGN: Cohort study with historical controls. SETTING: A 20-bed PICU in a freestanding, quaternary care, academic children's hospital. PATIENTS: This study included all patients admitted to the pediatric ICU between January 1, 2008, and December 31, 2009. A total of 818 discharges were evaluated prior to the intervention (January 1, 2008, through December 31, 2008) and 1,021 patient discharges were evaluated postintervention (January 1, 2009, through December 31, 2009). INTERVENTION: A computerized provider order entry rule limited the ability to schedule repeating complete blood cell counts, chemistry, and coagulation studies to a 24-hour interval in the future. The time limit was designed to ensure daily evaluation of the utility of each test. MEASUREMENTS AND MAIN RESULTS: Initial analysis with t tests showed significant decreases in tests per patient day in the postintervention period (complete blood cell counts: 1.5 ± 0.1 to 1.0 ± 0.1; chemistry: 10.6 ± 0.9 to 6.9 ± 0.6; coagulation: 3.3 ± 0.4 to 1.7 ± 0.2; p < 0.01, all variables vs. preintervention period). Even after incorporating a trend toward decreasing laboratory utilization in the preintervention period into our regression analysis, the intervention decreased complete blood cell counts (p = 0.007), chemistry (p = 0.049), and coagulation (p = 0.001) tests per patient day. CONCLUSIONS: Limits on laboratory orders within the context of computerized provider order entry decreased laboratory utilization without adverse affects on mortality or length of stay. Broader application of this strategy might decrease costs, the incidence of iatrogenic anemia, and catheter-associated bloodstream infections.
OBJECTIVES: To test the hypothesis that limits on repeating laboratory studies within computerized provider order entry decrease laboratory utilization. DESIGN: Cohort study with historical controls. SETTING: A 20-bed PICU in a freestanding, quaternary care, academic children's hospital. PATIENTS: This study included all patients admitted to the pediatric ICU between January 1, 2008, and December 31, 2009. A total of 818 discharges were evaluated prior to the intervention (January 1, 2008, through December 31, 2008) and 1,021 patient discharges were evaluated postintervention (January 1, 2009, through December 31, 2009). INTERVENTION: A computerized provider order entry rule limited the ability to schedule repeating complete blood cell counts, chemistry, and coagulation studies to a 24-hour interval in the future. The time limit was designed to ensure daily evaluation of the utility of each test. MEASUREMENTS AND MAIN RESULTS: Initial analysis with t tests showed significant decreases in tests per patient day in the postintervention period (complete blood cell counts: 1.5 ± 0.1 to 1.0 ± 0.1; chemistry: 10.6 ± 0.9 to 6.9 ± 0.6; coagulation: 3.3 ± 0.4 to 1.7 ± 0.2; p < 0.01, all variables vs. preintervention period). Even after incorporating a trend toward decreasing laboratory utilization in the preintervention period into our regression analysis, the intervention decreased complete blood cell counts (p = 0.007), chemistry (p = 0.049), and coagulation (p = 0.001) tests per patient day. CONCLUSIONS: Limits on laboratory orders within the context of computerized provider order entry decreased laboratory utilization without adverse affects on mortality or length of stay. Broader application of this strategy might decrease costs, the incidence of iatrogenic anemia, and catheter-associated bloodstream infections.
Authors: Natalie M Pageler; Christopher A Longhurst; Matthew Wood; David N Cornfield; Jaap Suermondt; Paul J Sharek; Deborah Franzon Journal: Pediatrics Date: 2014-02-24 Impact factor: 7.124
Authors: Mirela Prgomet; Ling Li; Zahra Niazkhani; Andrew Georgiou; Johanna I Westbrook Journal: J Am Med Inform Assoc Date: 2017-03-01 Impact factor: 4.497
Authors: Renuka S Bindraban; Maarten J Ten Berg; Christiana A Naaktgeboren; Mark H H Kramer; Wouter W Van Solinge; Prabath W B Nanayakkara Journal: Ann Lab Med Date: 2018-09 Impact factor: 3.464
Authors: Song Xu; Jason Hom; Santhosh Balasubramanian; Lee F Schroeder; Nader Najafi; Shivaal Roy; Jonathan H Chen Journal: JAMA Netw Open Date: 2019-09-04